Summary
The aim of this study was to find out whether only resistant cells of the “multidrug-resistant” phenotype show the described changes of plasma membrane glycoprotein (170 kDa) or whether resistant cells that do not express this phenotype reveal corresponding results. Doxorubicin-resistant (L1210dox) and daunorubicin-resistant L1210 ascites tumor cells (L1210dur) (multidrug-resistant tumor cells) were therefore compared with cytosine-arabinoside-resistant (L1210AraC) and cyclophosphamide-resistant L1210 ascites tumor cells (L1210ctx) (not multidrug-resistant tumor cells). The resistant cell lines were generated in vivo in tumor-bearing mice and the resistance to cytostatic agents was evaluated in vivo and in vitro. Using the accumulation assay with rhodamine-123, the multidrug resistance can be detected. In order to determine alterations in the plasma membranes we used the monoclonal antibodies 265/F4 and C219, which were prepared against the membrane glycoprotein P170 (170 kDa) in colchicin-resistant Chinese hamster ovary cells. The results demonstrate that L1210dox and L1210dnr tumor cells show an intense immunostaining by the streptavidin/biotinylated-peroxidase-complex method and by the streptavidin/biotin/phycoerythrin immunofluorescence method. In contrast no specific immunostaining was observed in parental (sensitive) and L1210AraC or L1210etx tumor lines. The results were confirmed by immunoblotting. To determine whether multidrug-resistant DNA sequences were expressed in the multidrug-resistant tumor cells, Northern blots with RNA od sensitive and resistant cells were performed using the clone pcDR1.5. Elevated RNA levels were detected only in resistant cells with the multidrug-resistant phenotype. Thus, the results of this study demonstrate that only resistant cells with the multidrug-resistant phenotype show an increased expression of the membrane 170-kDa glycoprotein.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bak M, Mattern J, Volm M (1987) Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. In vivo 1:319–326
Beck WT, Müller TJ, Tanzer LR (1979) Altered surface membrane glycoproteins in vinca alkaloid resistant human leukemia lymphoblasts. Cancer Res 39:2070–2076
Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V (1985) Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 3:311–315
Biedler JL, Chang T, Meyers MB, Peterson RHF, Sprengler BA (1983) Drug resistance in Chinese hamster lung and mouse tumor cell. Cancer Treat Rep 67:859–867
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Danø K (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochem Biophys Acta 323:466–483
Fairbanks G, Steck TL, Wallach DFH (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10:2606–2617
Gerlach JH, Bell DR, Karakousis G, Slocum HK, Kartner N, Rustum YM, Ling V, Baker RM (1987) Glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 5:1452–1460
Giavazzi R, Kartner N, Hart IR (1984) Expression of cell surface P-glycoprotein by an adriamycin-resistant murine fibrosarcoma. Cancer Chemother Pharmacol 13:145–147
Gros P, Croop J, Roninson I, Varshavsky A, Housman DE (1986) Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83:337–341
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152–162
Kartner N, Evernden-Porelle D, Bradley G, Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820–823
Lathan B, Edwards DP, Dressler LG, Von Hoff DD, McGuire WL (1985) Immunological detection of chinese hamster ovary cells expressing a multidrug resistance phenotype. Cancer Res 45:5064–5069
Ling V (1982) Genetic basis of drug resistance in mammalian cells. In: Bruchovsky N, Goldie JH (eds) Drug and hormone resistance in neoplasma, vol 1. CRC Press, Miami, pp 1–19
Mattern J, Volm M (1982) Clinical relevance of predictive test for cancer chemotherapy. Cancer Treat Rev 9:267–298
Riordan JR, Ling V (1979) Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254:12701–12705
Riordan JR, Ling V (1986) Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 28:51–75
Riordan JR, Denchars K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316:817–819
Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsky A (1984) Ampliciation of specific DNA sequences correlates with multidrug resistance in Chinese hamster cells. Nature 309:626–628
Shen D, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM (1986) Multiple drug-resistant human KB carcinoma cells independently delected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261:7762
Skovsgaard T (1978) Carrier-mediated transport of daunorubicin, adriamycin and rubidazone in Ehrlich ascites tumor cells. Biochem Pharmacol 27:1221–1227
Tapiero H, Munck JN, Fourcade A, Lampidis TJ (1984) Cross-resistance to rhodamine 123 in adriamycin- and daunorubicin-resistant Friend leukemia cell variants. Cancer Res 44:5544–5549
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Volm M, Brüggemann A, Günther M, Kleine W, Pfleiderer A, Vogt-Schaden M (1985) Prognostic relevance of ploidy, proliferation, and resistance predictive tests in ovarian carcinoma. Cancer Res 45:5180–5185
Volm M, Efferth TH, Günther A, Lathan B (1987) Detection of murine S 180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody. Arzneim Forsch Drug Res 37:862–867
Volm M, Drings P, Hahn EW, Mattern J (1988) Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test. Br J Cancer 57:198–200
Author information
Authors and Affiliations
Additional information
Guest Scientist from the National Institute of Oncology, Budapest Hungary
Rights and permissions
About this article
Cite this article
Volm, M., Bak, M., Efferth, T. et al. Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein. J Cancer Res Clin Oncol 115, 17–24 (1989). https://doi.org/10.1007/BF00391594
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00391594